McKesson Corporation (FRA:MCK)

Germany flag Germany · Delayed Price · Currency is EUR
667.20
-14.60 (-2.14%)
At close: Oct 17, 2025
-2.14%
Market Cap84.33B
Revenue (ttm)321.52B
Net Income (ttm)2.69B
Shares Outn/a
EPS (ttm)21.25
PE Ratio31.30
Forward PE20.00
Dividend2.68 (0.40%)
Ex-Dividend DateSep 2, 2025
Volume13
Average Volume42
Open657.80
Previous Close681.80
Day's Range657.40 - 667.20
52-Week Range457.00 - 681.80
Betan/a
RSI65.05
Earnings DateNov 5, 2025

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1833
Employees 45,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MCK
Full Company Profile

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD Financial Statements

News

There is no news available yet.